BridgeBio Pharma's total assets for Q4 2025 were $936.02M, a decrease of -6.23% from the previous quarter. BBIO total liabilities were $3.01B for the fiscal quarter, a 3.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.